LARGE-SCALE PREPARATION OF ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS FOR ADOPTIVE IMMUNOTHERAPY IN MAN

被引：2
|
作者：
MELDER, RJ
ROSENFELD, CS
HERBERMAN, RB
WHITESIDE, TL
机构：
[1] UNIV PITTSBURGH,MONTEFIORE HOSP,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15213
[2] UNIV PITTSBURGH,MONTEFIORE HOSP,SCH MED,DEPT MED,PITTSBURGH,PA 15213
[3] UNIV PITTSBURGH,MONTEFIORE HOSP,SCH MED,DIV CLIN IMMUNOPATHOL,PITTSBURGH,PA 15213
[4] PITTSBURGH CANC INST,PITTSBURGH,PA
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 1989年 / 29卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：67 / 73
页数：7
相关论文
共 50 条
  • [1] LYMPHOKINE-ACTIVATED KILLER (LAK) AND ADHERENT LAK (A-LAK) ACTIVITY IN MULTIPLE-SCLEROSIS
    SATOH, J
    KIM, SU
    KASTRUKOFF, LF
    JOURNAL OF NEUROIMMUNOLOGY, 1991, 32 (02) : 111 - 122
  • [2] AN ADOPTIVE IMMUNOTHERAPY OF PATIENTS WITH MEDULLOBLASTOMA BY LYMPHOKINE-ACTIVATED KILLER CELLS (LAK)
    OKAMOTO, Y
    SHIMIZU, K
    TAMURA, K
    MIYAO, Y
    YAMADA, M
    MATSUI, Y
    TSUDA, N
    TAKIMOTO, H
    HAYAKAWA, T
    MOGAMI, H
    ACTA NEUROCHIRURGICA, 1988, 94 (1-2) : 47 - 52
  • [3] PHENOTYPIC CHARACTERISTICS OF ADHERENT LYMPHOKINE ACTIVATED KILLER CELLS (A-LAK CELLS) IN MICE
    GUNJI, Y
    VUJANOVIC, NL
    HISERODT, JC
    GORELIK, E
    FASEB JOURNAL, 1988, 2 (04): : A462 - A462
  • [4] ADOPTIVE IMMUNOTHERAPY USING LYMPHOKINE-ACTIVATED KILLER CELLS
    FOWLER, JE
    JOURNAL OF UROLOGY, 1988, 139 (01): : 148 - 149
  • [5] THE GENERATION OF PURIFIED ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS IN PATIENTS WITH BENIGN AND MALIGNANT LIVER-TUMORS
    WHITESIDE, TL
    SCHWARZ, RE
    IWATSUKI, S
    HERBERMAN, RB
    FASEB JOURNAL, 1988, 2 (04): : A689 - A689
  • [6] A NEW PROCEDURE FOR LARGE-SCALE PRODUCTION AND FREEZING OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS TO BE USED IN ADOPTIVE IMMUNOTHERAPY OF CANCER
    GAMBACORTIPASSERINI, C
    RADRIZZANI, M
    RIVOLTINI, L
    MARCHESI, E
    RAVAGNANI, F
    SCIORELLI, G
    CASCINELLI, N
    PARMIANI, G
    TUMORI, 1988, 74 (05) : 523 - 530
  • [7] LOCO-REGIONAL IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND ADHERENT LYMPHOKINE-ACTIVATED KILLER-CELLS (A-LAK) IN RECURRENT GLIOBLASTOMA PATIENTS
    BOIARDI, A
    SILVANI, A
    RUFFINI, PA
    RIVOLTINI, L
    PARMIANI, G
    BROGGI, G
    SALMAGGI, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (03) : 193 - 197
  • [8] UNIMPAIRED ABILITY TO GENERATE ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS IN PATIENTS WITH PRIMARY OR METASTATIC LIVER-TUMORS
    SCHWARZ, RE
    IWATSUKI, S
    HERBERMAN, RB
    WHITESIDE, TL
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 30 (05) : 312 - 316
  • [9] REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
    KEILHOLZ, U
    SCHEIBENBOGEN, C
    BRADO, M
    GEORGI, P
    MACLACHLAN, D
    BRADO, B
    HUNSTEIN, W
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 103 - 105
  • [10] SURFACE AMINOPEPTIDASE ACTIVITY OF RAT ADHERENT-LYMPHOKINE ACTIVATED KILLER (A-LAK) CELLS
    AMOSCATO, AA
    BRUMFIELD, AM
    HERBERMAN, RB
    CHAMBERS, WH
    FASEB JOURNAL, 1992, 6 (04): : A1421 - A1421
12345